Regarding the Addition of CDK4/6 Inhibitor to Postoperative Endocrine Therapy in Patients With HR-Positive HER2-Negative High-Risk Breast Cancer.

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)

Keyphrases